Detalhe da pesquisa
1.
CUTL1 is a target of TGF(beta) signaling that enhances cancer cell motility and invasiveness.
Cancer Cell
; 7(6): 521-32, 2005 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-15950902
2.
Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen.
BMC Genomics
; 9: 239, 2008 May 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-18498629
3.
Risk estimation of distant metastasis in node-negative, estrogen receptor-positive breast cancer patients using an RT-PCR based prognostic expression signature.
BMC Cancer
; 8: 339, 2008 Nov 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-19025599
4.
Sialylated core 1 based O-linked glycans enhance the growth rate of mammary carcinoma cells in MUC1 transgenic mice.
Int J Oncol
; 25(4): 937-43, 2004 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-15375543
5.
Discrepancies between reported self-monitored blood glucose results and point-of-care hemoglobin A1c in children with diabetes: lessons to be learned.
Diabetes Technol Ther
; 14(5): 440-3, 2012 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-22309477
6.
Assay interference leading to misdiagnosis of central precocious puberty.
Endocrine
; 20(3): 195-9, 2003 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-12721497
7.
Pathologic quiz case: an 81-year-old woman with compression fracture and renal failure. Multiple myeloma with a monoclonal serum IgD lambda immunoglobulin.
Arch Pathol Lab Med
; 127(10): 1383-4, 2003 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-14521448
8.
Ductal in situ component and prognosis in invasive mammary carcinoma.
Breast Cancer Res Treat
; 84(2): 197-8, 2004 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-15069931
9.
A high number of tumor free axillary lymph nodes from patients with lymph node negative breast carcinoma is associated with poor outcome.
Cancer
; 94(8): 2307-9, 2002 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-12001132